◆英語タイトル:LeMaitre Vascular Inc (LMAT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011065
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular procedures, which include balloon catheters, carotid shunts, powered phlebectomy, laparoscopic cholecystectomy devices, manual contrast injectors, modeling catheters, radiopaque tape, remote endarterectomy devices, valvulotomes, vascular grafts, vascular patches, vein strippers and vessel closure systems. LeMaitre Vascular sells its products through direct sales force in North America, Europe, Japan, China and Australia and through distributors in other geographies. The company operates sales offices in Tokyo, Japan; Mississauga, Canada; Madrid, Spain; Milan, Italy; Shanghai, China; and North Melbourne, Australia. LeMaitre Vascular is headquartered in Burlington, Massachusetts, the US.
LeMaitre Vascular Inc (LMAT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LeMaitre Vascular Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LeMaitre Vascular Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LeMaitre Vascular Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 10
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 11
LeMaitre Vascular Acquires ProCol Vascular Bioprosthesis Product Line from Hancock Jaffe Labs for USD0.6 Million 12
LeMaitre Vascular Acquires Angioscope Product Line from Applied Medical for USD0.4 Million 13
LeMaitre Vascular To Acquire Assets Of InaVein For US$2.5 Million 14
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 15
Venture Financing 17
Restore Flow Allografts Raises US$0.7 Million In Venture Financing 17
Equity Offering 18
LeMaitre Vascular Raises USD11.5 Million in Public Offering of Shares 18
Asset Transactions 20
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 20
Acquisition 21
LeMaitre Vascular Acquires Xenotis for USD7.7 Million 21
LeMaitre Vascular Acquires Clinical Instruments International For US$1 Million 22
LeMaitre Vascular Inc – Key Competitors 23
LeMaitre Vascular Inc – Key Employees 24
LeMaitre Vascular Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Financial Announcements 27
Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%) 27
Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 28
Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 29
Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 30
Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 31
Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 32
May 02, 2016: LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%) 33
Feb 24, 2016: LeMaitre Q4 2015 Record Sales $20.5mm (+14% organic), Record Net Income $2.5mm (+32%) 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
LeMaitre Vascular Inc, Medical Equipment, Key Facts, 2016 2
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LeMaitre Vascular Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LeMaitre Vascular Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LeMaitre Vascular Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LeMaitre Vascular Inc, Deals By Market, 2011 to YTD 2017 8
LeMaitre Vascular Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 10
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 11
LeMaitre Vascular Acquires ProCol Vascular Bioprosthesis Product Line from Hancock Jaffe Labs for USD0.6 Million 12
LeMaitre Vascular Acquires Angioscope Product Line from Applied Medical for USD0.4 Million 13
LeMaitre Vascular To Acquire Assets Of InaVein For US$2.5 Million 14
LeMaitre Vascular Finalizes Acquisition of XenoSure From Neovasc For US$5 Million 15
Restore Flow Allografts Raises US$0.7 Million In Venture Financing 17
LeMaitre Vascular Raises USD11.5 Million in Public Offering of Shares 18
LeMaitre Vascular Acquires Assets of Restore Flow Allografts 20
LeMaitre Vascular Acquires Xenotis for USD7.7 Million 21
LeMaitre Vascular Acquires Clinical Instruments International For US$1 Million 22
LeMaitre Vascular Inc, Key Competitors 23
LeMaitre Vascular Inc, Key Employees 24
LeMaitre Vascular Inc, Subsidiaries 25